22 May 2013
Keywords: galapagos, biofocus, unit, three-year, deal, roche, belgian
Article | 03 April 2006
Belgian genomics-based drug discovery firm Galapagos says that its service division, BioFocus, has entered into a three-year collaboration
with Swiss ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 April 2006
21 May 2013
© 2013 thepharmaletter.com